The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives

Journal of Clinical Pharmacology

Volumn 42, Issue 4, 2002, Pages 365-375

  Tishler, Carl L ^a   Bartholomae, Suzanne ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PHARMACOLOGY; ETHICS; FINANCE; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN EXPERIMENT; MOTIVATION; NORMAL HUMAN; PRACTICE GUIDELINE; REVIEW; REWARD; VOLUNTEER;

EID: 0036209896     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700222011409     Document Type: Review

References (70)

1. Permissible medical experiments
2. The Belmont report: Ethical principles and guidelines for protection of human subjects of research (1974)
3. Attitudes toward clinical trials among patients and the public
4. Clinical profiles of paid normal subjects volunteering for hallucinogen drug studies
5. On paying money to research subjects
6. Participation of healthy volunteers in research projects
7. Guidelines for accepting volunteers: Consent, ethical implications and the function of a peer review
8. Addressing ethical issues in the psychiatric research literature
9. Research, unethical
10. Research, human: Ethical aspects
11. Remembering and interpreting informed consent: A qualitative study of drug trial participants
12. Administrative developments: New human subject research guidelines for IRBs
13. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers
14. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans
15. Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects
16. Subject recruitment bias: The paid volunteer subject
17. Drug trials on healthy volunteers in Yugoslavia
18. Beyond respect for persons and beneficence: Justice in research
19. Volunteers for biomedical research: Recruitment and screening of normal controls
20. An ethical framework for the practice of paying research subjects
21. Research incentives: Money versus gifts
22. Evidence-based ethics and informed consent in mental illness research
23. What's the price of a research subject? Approaches to payment for research participation
24. Ethical parameters of challenge studies inducing psychosis with ketamine
25. Healthy volunteer studies in Great Britain: The results of a survey into 12 months activity in this field
26. Payments to healthy volunteers: Ethical problems
27. Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers
28. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses
29. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
30. NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers
31. Comparison of ketamine and thiopental in healthy volunteers: Effects on mental status, mood, and personality
32. Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors
33. Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)-and (R)-ketamine in healthy volunteers using positron emission tomography (PET)
34. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]-fluorodeoxyglucose (FDG)
35. How much are subjects paid to participate in research?
36. Motivations and rewards for volunteering to be an experimental subject
37. Motives and perception of healthy volunteers who participate in experiments
38. Inducement, due and otherwise
39. Weight of financial reward in the decision by medical students and experienced healthy volunteers to participate in clinical trials
40. Free-living volunteer's motivations and attitudes toward pharmacologic studies in man
41. Paid in full?
42. Human subjects in clinical research: A report of three studies
43. Motivations for volunteering as research subjects
44. Payments to research participants: The importance of context
45. Money for research participation: Does it jeopardize informed consent?
46. Do medical student research subjects need special protection?
47. What's the price of a research subject?
48. A piece of my mind: Subject to payment?
49. Socio-economic status and inducement to participate
50. Socioeconomic status and health: The challenge of gradient
51. Economic stress and psychological well-being: An economic psychology framework
52. Drug trials hide conflicts for doctors
53. Doing harm: Research on the mentally ill
54. What's the price of a research subject?
55. Paying research subjects: Participants' perspectives
56. Questionable methods in alcoholism research
57. Prepaid incentives yield higher rates to mail surveys
58. Physician response to a mailed survey: An experiment in timing of payment
59. Effect of timed incentives on subject participation in a study of long-term breast cancer survivors: Are there ethnic differences?
60. Therapeutic trial participants: Where do we find them and what does it cost?
61. Normal controls and biological reference values in child psychiatry: Defining normal
62. Professional integrity in clinical research